Pharmacologist and cancer researcher at Bristol Myers Squibb Company.
Education
- PhD, University of California, San Francisco (2008-2013)
Research Interests
Keywords:
Pharmacology Drug Development Cancer Research
Topics:
Pharmacology Drug Development Oncology
Professional Links
Selected Publications
S100A3 protein reduces PAH risk
Zhao W, Chen Y, Yu Z, Wang Z, He R, et al. Risk associated circulating biomarkers S100A3 identified in congenital heart disease-associated pulmonary arterial hypertension. Intractable Rare Dis Res. 2025;14:36. doi:10.5582/irdr.2024.01064
Related Products
Products associated with this researcher's work:
Related to: Heart+disease